过去一年中添加的文章，按日期排序
[HTML] mdpi.com

[HTML][HTML] Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune Diseases

N Riva, L Brstilo, A Sancho-Araiz, M Molina… - Pharmaceutics, 2023 - mdpi.com
249 天前 - … in children lead to increased off-label use of rituximab. We … B lymphocytes (CD19+)
under treatment with intravenous rituximab in children with neurologic and autoimmune …
相关文章 所有 13 个版本

Pharmacodynamics of rituximab in paediatric immune mediated diseases: B cell depletion and repopulation, effects on immunoglobulin levels and risk for infections

ANS Rashid, SC Bergkamp… - Clinical and …, 2023 - pubmed.ncbi.nlm.nih.gov
347 天前 - … repopulation in paediatric immune-mediated diseases and … of children with
autoimmune diseases (AID), immune … significantly differ between paediatric patient groups. Severe …
相关文章 所有 3 个版本
[PDF] clinexprheumatol.org

[PDF][PDF] Paediatric rheumatology Pharmacodynamics of rituximab in paediatric immune mediated diseases: B cell depletion and repopulation, effects on …

ANS Rashid, SC Bergkamp… - Clinical and …, 2023 - clinexprheumatol.org
353 天前 - … In other autoimmune diseases, such as systemic lupus erythematosus (SLE) and
ANCA… time to B cell repopulation after RTX treatment in different paediatric patient populations …
相关文章